00000000nam 2200000zi 4500
0019.950701
003CaOODSP
00520250530133041
006m     o  d f      
007cr mn|||||||||
008250501e202505  onc     ob   f000 0 eng d
020 |a9780660771083 |q(statement)
020 |a9780660771090 |q(summary)
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-388/2025E-PDF
0861 |aHP40-388/2025-1E-PDF
24500|aUpdated recommendations on herpes zoster vaccination for adults who are immunocompromised.
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cMay 2025.
264 4|c©2025
300 |a1 online resource (27 pages) + |esummary (4 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Recommandations mises à jour sur la vaccination contre le zona chez les adultes immunodéprimés.
500 |aOn cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI).
500 |a"Pub.: 250041"--Page 2.
500 |a"Pub.: 250043"--Page 2 (summary).
504 |aIncludes bibliographical references (pages 23-27).
650 0|aShingles (Disease)|xVaccination|xGovernment policy|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
7101 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body.
77508|tRecommandations mises à jour sur la vaccination contre le zona chez les adultes immunodéprimés.|w(CaOODSP)9.950706
85640|qPDF|s602 KB|uhttps://publications.gc.ca/collections/collection_2025/aspc-phac/HP40-388-2025-eng.pdf|z(statement)
85640|qPDF|s202 KB|uhttps://publications.gc.ca/collections/collection_2025/aspc-phac/HP40-388-2025-1-eng.pdf|z(summary)
986 |a250041
986 |a250043